Northwestern Medicine scientists have identified the unique targets of two enzymes that activate ubiquitination, a key modification of proteins that controls a variety of cellular processes.
A Northwestern Medicine study, led by a PhD student, found that overexpressing a protein called CREB improved memory impairments in aged rats.
Northwestern and Stanford scientists have uncovered new details on the structure of herpesviruses that allow them to initiate a fusion event to infect host cells.
Northwestern Medicine scientists have demonstrated an enhanced approach to targeting a type of inflammatory cell involved in atherosclerosis.
From 3-D printed hyperelastic bones to the nuclear membrane of immature red blood cells, scientific images bring to life the range of research published by Feinberg faculty and students in 2016.
Northwestern Medicine scientists showed how a microRNA family regulates aspects of autophagy and macropinocytosis in the stem cell–enriched limbal epithelium of the eye.
Northwestern Medicine scientists have demonstrated an alternate method of signaling used by proteins called group I metabotropic glutamate receptors, a finding that could be used to develop novel drug treatments for many neurological disorders.
Northwestern Medicine scientists are exploring a new drug that could make people healthier for longer by slowing the aging process.
A new strategy for targeting a protein called GRP78 could be used to simultaneously provide diagnostic imaging and deliver treatment for inflammatory breast cancer, according to a recent study.
A Northwestern Medicine study, led by a fifth-year PhD student, has demonstrated that a cytokine known to be important in allergic disease called interleukin-33 (IL-33) plays a key role regulating stem cells under normal, healthy conditions.
Notifications